FDA grants early approval for Ultomiris for the treatment of adults with PNH Dec. 24, 2018 No Comments
Elzonris receives FDA approval for the treatment of blastic plasmacytoid dendritic cell neoplasm Dec. 24, 2018 No Comments
FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain Dec. 3, 2018 No Comments
Melinta Therapeutics granted marketing authorization for Vabomere in Europe Nov. 28, 2018 No Comments
FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion Nov. 27, 2018 No Comments
RSS